78 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
the United States, a product must be approved for reimbursement before the product can be approved for sale in that country. We may not obtain approvals … requirements, labor laws and anti-competition regulations;
export and import restrictions;
various reimbursement and insurance regimes;
laws and business
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
, in many countries outside the United States, a product must be approved for reimbursement before the product can be approved for sale in that country. We … Act, data privacy requirements, labor laws and anti-competition regulations;
export and import restrictions;
various reimbursement and insurance
S-1
AXDX
Accelerate Diagnostics Inc
13 Dec 23
IPO registration
5:30pm
countries and can involve additional testing. In addition, in many countries outside the United States, a product must be approved for reimbursement … and import restrictions;
various reimbursement and insurance regimes;
laws and business practices favoring local companies;
longer payment cycles
8-K
EX-99.1
ke6w191c4do0l31
13 Dec 23
December 2023 Company Presentation
5:05pm
8-K
EX-10.3
ox12lo78373
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-4.1
3a7uz2z j5e
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.2
4ux1e
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
s6s xzn04vl8f48i
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
6jir6c2oxtrhwm
21 Apr 23
Entry into a Material Definitive Agreement
9:20pm
8-K
EX-10.1
bkghsemm6 72hr423skr
13 Dec 22
Departure of Directors or Certain Officers
5:25pm
424B5
b56dzj35zm qfw
22 Aug 22
Prospectus supplement for primary offering
4:11pm
424B5
w7lde0o7231gvczru4a3
17 Aug 22
Prospectus supplement for primary offering
6:13pm
8-K
EX-10.4
rirq nk72wt
15 Aug 22
Accelerate Diagnostics Reports Second Quarter 2022 Financial Results
8:26am